SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is buzzing as its dedicated community consistently drives real-world utility, launching numerous decentralized businesses and initiatives like Kendu Spice and the Kendu Unleashed sports brand. This relentless focus on building tangible products and an extensive IRL presence across multiple blockchains is fueling strong bullish sentiment, with many believing KENDU is an unstoppable 'permissionless brand' destined for widespread adoption.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining is seeing significant attention driven by substantial share acquisitions from prominent investor Eric Sprott and its recently achieved debt-free status. The community is actively discussing the company's large gold and silver reserves, celebrating long-awaited gains, and anticipating further appreciation amidst a broader rally in precious metal prices.

SPX6900 is an advanced blockchain cryptography token coin capable of limitless possibilities and scientific utilization.

SPX6900

SPX CRYPTO is trending with strong bullish sentiment, fueled by its highly anticipated listing on Coinbase. The community, often referring to it as SPX6900, is rallying with "diamond hands" and a "DCA" mindset, believing it represents a generational opportunity to potentially flip the traditional stock market. Many see it as a future blue-chip meme asset, drawing parallels to earlier explosive, community-driven movements in the crypto sector.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is actively discussed following a landmark 50/50 joint venture with Romania's state-owned FPCU, establishing Europe's first integrated rare earth processing facility and securing a significant portion of Tanbreez's output without capital expenditure. This non-dilutive partnership, aimed at bolstering Western critical mineral supply chains and attracting substantial EU funding, has ignited strong bullish sentiment among investors despite a temporary delay in the Bank Feasibility Study. Community conversations highlight the strategic geopolitical importance of this move for rare earth independence from China, alongside positive drill results confirming the project's rich heavy rare earth and strategic metal presence.

ETF Opportunities Trust - T-REX 2X Long BMNR Daily Target ETF

T-REX 2X Long BMNR Daily Target ETF

BMNU is trending as a 2x leveraged ETF directly tied to Ethereum's performance, fueled by widespread community speculation about an imminent ETH breakout and broader adoption of crypto rails by traditional finance. While many investors are actively "loading up on dips" anticipating substantial gains and a "mega pump" in Ethereum, significant caution is also being discussed due to the ETF's inherent decay and highly volatile price action.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix (OCUL) is currently generating significant buzz after a strategic 8-K filing indicated plans to accelerate the NDA submission for its wet AMD treatment, Axpaxli, using year-one SOL-1 trial data. This bold move has fueled intense debate among investors, with bulls anticipating a potential acquisition or partnership due to de-risked data, while skeptics point to recent price volatility, options expiration influence, and past dilutions.

SharpLink Gaming, Inc. is an online performance-based marketing company, which engages in the provision of online platform facilitating sports betting. It connects sports fans, leagues, and sports websites to relevant and timely sports betting content. The company was founded by Robert Phythian in 2019 and is headquartered in Minneapolis, MN.

SharpLink Gaming Inc.

SharpLink Gaming Ltd

SharpLink Gaming is trending as the community debates its future, driven by anticipation for Ethereum's upcoming Fusaka Upgrade, which bulls believe will significantly boost SBET's core digital asset treasury and staking rewards. While some point to a recent analyst upgrade and considerable short interest as potential catalysts for a rally, a vocal segment of investors expresses frustration over perceived underperformance and management challenges. The broader conversation centers on SBET's ability to capitalize on the ongoing tokenization of financial assets amid its close ties to Ethereum's ecosystem.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS Health is trending due to recent analyst upgrades and a raised profit outlook from its investor day, signaling disciplined execution and turnaround momentum. The community is discussing CVS's strategic moves in health services, strong Aetna Medicare Advantage ratings, and a broader "flight to safety" into the healthcare sector, contributing to its positive sentiment.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending due to a significant market debate surrounding its valuation amidst intensified autonomous vehicle (AV) competition and recent regulatory pressure on its Uber One subscription service. Many investors are seizing the current pullback as a prime buying opportunity, emphasizing Uber's global scale, established user base, and strategic AV partnerships, while others remain cautious about the long-term impact of emerging robotaxi services. This dynamic reflects a polarizing view on whether Uber will be a leader or a casualty in the evolving mobility landscape.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is currently trending due to a bullish 'Overweight' initiation from KeyBanc with a notable price target, intensifying community excitement around its potential. Traders are heavily anticipating an imminent NASA Lunar Terrain Vehicle (LTV) contract award, a catalyst amplified by a recent presidential executive order pushing for American space superiority. This, combined with high trading volume and discussions of a short squeeze, underscores the strong bullish sentiment within the emerging space sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 7.5% - Here's What Happened

Oric Pharmaceuticals (NASDAQ:ORIC) Trading Down 7.5% - Here's What Happened...

Oric Pharmaceuticals, Inc. $ORIC Shares Sold by EcoR1 Capital LLC

EcoR1 Capital LLC decreased its position in shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 52.7% during the second quarter, according to its most recent 13F filing with the...

Stempoint Capital LP Makes New Investment in Oric Pharmaceuticals, Inc. $ORIC

Stempoint Capital LP purchased a new stake in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the...

Vivo Capital LLC Has $31.74 Million Stock Holdings in Oric Pharmaceuticals, Inc. $ORIC

Vivo Capital LLC lifted its stake in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 50.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The...

Resolute Capital Asset Partners LLC Invests $2.31 Million in Oric Pharmaceuticals, Inc. $ORIC

Resolute Capital Asset Partners LLC acquired a new stake in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and...

Oric Pharmaceuticals' (ORIC) Outperform Rating Reaffirmed at Wedbush

Wedbush reissued an "outperform" rating and set a $20.00 price target on shares of Oric Pharmaceuticals in a report on Monday...

JPMorgan Chase & Co. Raises Stake in Oric Pharmaceuticals, Inc. $ORIC

JPMorgan Chase & Co. increased its holdings in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 3,646.1% during the 2nd quarter, according to the company in its most recent 13F filing with...

Geode Capital Management LLC Trims Stock Position in Oric Pharmaceuticals, Inc. $ORIC

Geode Capital Management LLC lowered its stake in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 15.1% during the second quarter, according to the company in its most recent filing with...

Oric Pharmaceuticals (NASDAQ:ORIC) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen downgraded shares of Oric Pharmaceuticals from a "hold" rating to a "sell" rating in a research note on Sunday...

Oric Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up - Should You Buy?

Oric Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up - Time to Buy...

Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.

Current Price	$8.04
Prev Close	$8.09
Open	$8.16
Dividend Yield	0.00%
50-Day Moving Average	$11.75
Beta	1.45
Avg. Volume	1.18M
PE Ratio	-4.64

52-Week High	$14.93
52-Week Low	$3.90
Market Capitalization	$787.39M
EPS (Annual)	-$1.83
Price to Book	1.92
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

ORIC
ORIC Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ORIC News

ORICORIC Pharmaceuticals Inc